Abstract:BACKGROUND/AIMS:Osteoporosis is a progressive bone disease characterized by a decrease in bone mass and density, which results in an increased risk of fractures. Mesenchymal stem cells (MSCs) are progenitor cells that can differentiate into osteoblasts, osteocytes and adipocytes in bone and fat formation. A reduction in the differentiation of MSCs into osteoblasts contributes to the impaired bone formation observed in osteoporosis. MicroRNAs (miRNAs) play a regulatory role in osteogenesis and MSC differentiation. MiR-27a has been reported to be down-regulated in the development of osteoporosis and during adipogenic differentiation.METHODS:In this study, a miRNA microarray analysis was used to investigate expression profiles of miRNA in the serum of osteoporotic patients and healthy controls and this data was validated by quantitative real-time PCR (qRT-PCR). MSCs isolated from human and mice with miR-27a inhibition or overexpression were induced to differentiate into osteoblasts or adipocytes. TargetScan and PicTar were used to predict the target gene of miR-27a. The mRNA or protein levels of several specific proteins in MSCs were detected using qRT-PCR or western blot analysis. Ovariectomized mice were used as in vivo model of human postmenopausal osteoporosis for bone mineral density measurement, micro-CT analysis and histomorphometric analysis.RESULTS:Here, we analyzed the role of miR-27a in bone metabolism. Microarray analysis indicated that miR-27a expression was significantly reduced in osteoporotic patients. Analysis on MSCs derived from patients with osteoporosis indicated that osteoblastogenesis was reduced, whereas adipogenesis was increased. MSCs that had undergone osteoblast induction showed a significant increase in miR-27a expression, whereas cells that had undergone adipocyte induction showed a significant decrease in miR-27a expression, indicating that miR-27a was essential for MSC differentiation. We demonstrated that myocyte enhancer factor 2 c (Mef2c), a transcription factor, was the direct target of miR-27a using a dual luciferase assay. An inverse relationship between miR-27a expression and Mef2c expression in osteoporotic patients was shown. Silencing of miR-27a decreased bone formation, confirming the role of miR-27a in bone formation in vivo.CONCLUSION:In summary, miR-27a was essential for the shift of MSCs from osteogenic differentiation to adipogenic differentiation in osteoporosis by targeting Mef2c.

Tumour Necrosis Factor Α Regulates the Mir‐27a‐3p–sfrp1 Axis in a Mouse Model of Osteoporosis

Tumor Necrosis Factor-α Inhibits Bone Marrow Stem Cell Differentiation into Osteoblasts by Downregulating Microrna-34A Expression.

Tumor necrosis factor α suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis.

TNF-αinhibits Mbmscs Osteoporosis Through Mir-21

MiR-27a Targets sFRP1 in hFOB Cells to Regulate Proliferation, Apoptosis and Differentiation

MiR-27a is Essential for the Shift from Osteogenic Differentiation to Adipogenic Differentiation of Mesenchymal Stem Cells in Postmenopausal Osteoporosis.

MiR-1-3p Regulates the Differentiation of Mesenchymal Stem Cells to Prevent Osteoporosis by Targeting Secreted Frizzled-Related Protein 1

Dysregulation of the Mir-146A-smad4 Axis Impairs Osteogenesis of Bone Mesenchymal Stem Cells under Inflammation

miRNA-27a is essential for bone remodeling by modulating p62-mediated osteoclast signaling

Virtual Screening Identified Natural Keap1-Nrf2 PPI Inhibitor Alleviates Inflammatory Osteoporosis Through Nrf2-mir214-Traf3 Axis.

Tumour necrosis factor-α promotes BMHSC differentiation by increasing P2X7 receptor in oestrogen-deficient osteoporosis

Mir-155 Modulates TNF-α-inhibited Osteogenic Differentiation by Targeting SOCS1 Expression

MicroRNA-27a is essential for bone remodeling by modulating p62-mediated osteoclast signaling

TNF-α-induced NF-κB Activation Upregulates Microrna-150-3p and Inhibits Osteogenesis of Mesenchymal Stem Cells by Targeting Β-Catenin.

MicroRNA-18a regulates the Pyroptosis, Apoptosis, and Necroptosis (PANoptosis) of osteoblasts induced by tumor necrosis factor-α via hypoxia-inducible factor-1α

MiR-27a-3p Targets GLP1R to Regulate Differentiation, Autophagy, and Release of Inflammatory Factors in Pre-Osteoblasts via the AMPK Signaling Pathway

The Regulatory Effect of Mir-181c-5p On the Differentiation Function of Bone Marrow Mesenchymal Stem Cells in Postmenopausal Osteoporotic Mice

MiR-27a-3p promotes the osteogenic differentiation by activating CRY2/ERK1/2 axis

Exploration of the Mir-187-3p/cnr2 Pathway in Modulating Osteoblast Differentiation and Treating Postmenopausal Osteoporosis Through Mechanical Stress.

TNF-α Inhibits FoxO1 by Upregulating Mir-705 to Aggravate Oxidative Damage in Bone Marrow-Derived Mesenchymal Stem Cells During Osteoporosis

Mir-664-3p Suppresses Osteoblast Differentiation And Impairs Bone Formation Via Targeting Smad4 And Osterix